Lukas E. Dow
- Aging top 2%
- Molecular Biology top 1%
- CRISPR and Genetic Engineering 27
- Wnt/β-catenin signaling in development and cancer 11
- RNA Interference and Gene Delivery 8
- Advanced biosensing and bioanalysis techniques 6
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 6
- Cell Biology top 1%
- Hippo pathway signaling and YAP/TAZ 7
-
- Cancer Cells and Metastasis 11
-
- Virus-based gene therapy research 7
- Co-authors
- Scott W. LowePatrick O. HumbertEmma M. SchatoffKevin P. O’RourkeDarjus F. TschaharganehAlyna KattiBenjamin I. LeachSarah M. Russell
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Lukas E. Dow
72 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Aging 118
- Molecular Biology 4.1k
- Business and International Management 113
- Cancer Research 812
- Cell Biology 812
Countries citing papers authored by Lukas E. Dow
This map shows the geographic impact of Lukas E. Dow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas E. Dow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas E. Dow more than expected).
Fields of papers citing papers by Lukas E. Dow
This network shows the impact of papers produced by Lukas E. Dow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas E. Dow. The network helps show where Lukas E. Dow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lukas E. Dow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 21 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 21 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 82 | |
| 9 | 2020 | 43 | |
| 10 | 2020 | 71 | |
| 11 | 2020 | 25 | |
| 12 | 2020 | 46 | |
| 13 | 2019 | 56 | |
| 14 | 2019 | 3 | |
| 15 | 2019 | 138 | |
| 16 | Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDHbreakdown → | 2015 | 696 |
| 17 | 2011 | 143 | |
| 18 | 2010 | 193 | |
| 19 | 2006 | 121 | |
| 20 | 1998 | 110 |
About Lukas E. Dow
Lukas E. Dow is a scholar working on Aging, Molecular Biology and Cancer Research, having authored 73 papers that have together received 6.0k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (27 papers), Cancer Cells and Metastasis (11 papers), Wnt/β-catenin signaling in development and cancer (11 papers), RNA Interference and Gene Delivery (8 papers), Virus-based gene therapy research (7 papers), Hippo pathway signaling and YAP/TAZ (7 papers), Cancer Genomics and Diagnostics (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Aging (118 citations), Molecular Biology (4.1k citations) and Business and International Management (113 citations). Lukas E. Dow has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Scott W. Lowe, Patrick O. Humbert, Emma M. Schatoff, Kevin P. O’Rourke, Darjus F. Tschaharganeh, Alyna Katti, Benjamin I. Leach, Sarah M. Russell, Ashlesha Muley and Hans Clevers. Their work appears in journals such as Nature Biotechnology, Cancer Research, Cancer Discovery, Cell Reports and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.